ArticleOncotarget2015

Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.

Maria Inés Molejon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.